EDITAS MEDICINE, INC. Common Stock, Capital Shares Reserved for Future Issuance
EDITAS MEDICINE, INC. (EDIT) had Common Stock, Capital Shares Reserved for Future Issuance of 24.01 million shares as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-09
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 24.01M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 22.69M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.54M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 17.89M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 24.01M shares 10-K · filed 2026-03-09 |
| 2024-12-31 | 22.69M shares 10-K · filed 2026-03-09 |
| 2023-12-31 | 20.54M shares 10-K · filed 2025-03-05 |
| 2022-12-31 | 17.89M shares 10-K · filed 2024-02-28 |
| 2021-12-31 | 13.84M shares 10-K · filed 2023-02-22 |
| 2020-12-31 | 12.03M shares 10-K · filed 2022-02-24 |
| 2019-12-31 | 10.43M shares 10-K · filed 2021-02-26 |
| 2018-12-31 | 9.10M shares 10-K · filed 2020-02-26 |
| 2017-12-31 | 7.62M shares 10-K · filed 2019-03-01 |
| 2016-12-31 | 6.31M shares 10-K · filed 2018-03-08 |
| 2015-12-31 | 29.48M shares 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |